The flumazenil market was estimated at around USD 18.5 million in 2021, growing at a CAGR of nearly 2.8% during 2022-2030. The market is projected to reach approximately USD 23.7 million by 2030. Flumazenil is a benzodiazepine inhibitor used to reverse the effects of postoperative drowsiness brought on by benzodiazepine anesthetics.
1xbet
Onmusic Ai
Qualitymarketing Org
Debet Contractors
Dgc Education Group
Noah Becker
Casinopribetco
My Health Network
B52club Siro
789bets